keyword
https://read.qxmd.com/read/38676751/quantification-of-vascular-changes-in-macular-telangiectasia-type-2-with-angiotool-software
#1
JOURNAL ARTICLE
Indu Govindaraj, Maanasi Mahalingam, Uma Maheswari, H S Yeshwanth Kumar, B S Suganya, Vishnu Subramanian, Anand Rajendran
PURPOSE: To compare AngioTool (AT) vascular parameters (VP) between MacTel2 eyes and normal eyes. Secondary outcome measures were to correlate VP with BCVA and to analyze VP between various grades of Simple MacTel Classification. METHODS: This is a retrospective study. SD OCTA images of the superficial vascular complex (SVC) and deep capillary complex (DVC) were exported into Image J and AT. The explant area (EA), vessel area (VA), vessel percentage area (VPA), total number of junctions (TNJ), junction density (JD), total vessel length (TVL), average vessel length (AVL), total number of endpoints (TNE) and mean E lacunarity (MEL) were studied...
April 27, 2024: Graefe's Archive for Clinical and Experimental Ophthalmology
https://read.qxmd.com/read/38554790/encapsulated-cell-technology-delivering-cytokines-to-treat-posterior-ocular-diseases
#2
REVIEW
Jiale Wang, Wenhui Fan, Bo Liu, Ning Pu, Hao Wu, Rongyue Xue, Siyu Li, Zongming Song, Ye Tao
Encapsulated cell technology (ECT) is a targeted delivery method that uses the genetically engineered cells in semipermeable polymer capsules to deliver cytokines. Thus far, ECT has been extensively utilized in pharmacologic research, and shows enormous potentials in the treatment of posterior segment diseases. Due to the biological barriers within the eyeball, it is difficult to attain effective therapeutic concentration in the posterior segment through topical administration of drug molecules. Encouragingly, therapeutic cytokines provided by ECT can cross these biological barriers and achieve sustained release at the desired location...
March 28, 2024: Pharmacological Research: the Official Journal of the Italian Pharmacological Society
https://read.qxmd.com/read/38513243/ellipsoid-zone-recovery-in-macular-telangiectasia-type-2-mactel
#3
JOURNAL ARTICLE
Lukas Goerdt, Kristin Raming, José Luis Rodriguez Garcia, Kristina Pfau, Frank G Holz, Philipp Herrmann
PURPOSE: To describe imaging features of Macular Telangiectasia Type 2 (MacTel) eyes experiencing ellipsoid zone (EZ) recovery. METHODS: MacTel patients with EZ-recovery were identified from the Natural History and Observational Registry Study and underwent retinal imaging including optical coherence tomography (OCT) and fundus photography. Eyes were graded according to the classification system by Gass and Blodi, the EZ-loss area was measured and OCT parameters were assessed by two independent readers...
March 14, 2024: Retina
https://read.qxmd.com/read/38475930/sight-threatening-diabetic-retinopathy-in-patients-with-macular-telangiectasia-type-2
#4
JOURNAL ARTICLE
Josef Huemer, Tjebo Fc Heeren, Abraham Olvera-Barrios, Livia Faes, Antonio M B Casella, Edward Hughes, Adnan Tufail, Catherine Egan
PURPOSE: Although diabetes is highly prevalent in patients with MacTel, progression to severe non-proliferative (NPDR) and proliferative diabetic retinopathy (PDR) is rarely reported. We report multimodal imaging features of sight-threatening diabetic retinopathy (STDR) in eyes with macular telangiectasia type 2 (MacTel). METHODS: Retrospective case series of seven participants of the MacTel Study at the Moorfields Eye Hospital NHS Foundation Trust study site and one patient from the Institute of Retina and Vitreous of Londrina, Brazil...
March 12, 2024: International Journal of Retina and Vitreous
https://read.qxmd.com/read/38329740/self-supervised-learning-for-improved-optical-coherence-tomography-detection-of-macular-telangiectasia-type-2
#5
JOURNAL ARTICLE
Shahrzad Gholami, Lea Scheppke, Meghana Kshirsagar, Yue Wu, Rahul Dodhia, Roberto Bonelli, Irene Leung, Ferenc B Sallo, Alyson Muldrew, Catherine Jamison, Tunde Peto, Juan Lavista Ferres, William B Weeks, Martin Friedlander, Aaron Y Lee
IMPORTANCE: Deep learning image analysis often depends on large, labeled datasets, which are difficult to obtain for rare diseases. OBJECTIVE: To develop a self-supervised approach for automated classification of macular telangiectasia type 2 (MacTel) on optical coherence tomography (OCT) with limited labeled data. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective comparative study. OCT images from May 2014 to May 2019 were collected by the Lowy Medical Research Institute, La Jolla, California, and the University of Washington, Seattle, from January 2016 to October 2022...
February 8, 2024: JAMA Ophthalmology
https://read.qxmd.com/read/38261977/methylation-associated-pathways-in-macular-telangiectasia-type-2-and-ophthalmologic-findings-in-patients-with-genetic-methylation-disorders
#6
JOURNAL ARTICLE
Laurenz Pauleikhoff, Victoria Wingert, Sarah C Grünert, Clemens Lange, Luciana Hannibal, Felicitas Bucher
PURPOSE: Serine (Ser) and glycine (Gly) levels were reported to differ between Macular telangiectasia type 2 (MacTel) patients compared to healthy controls. Since they are closely related to methylation metabolism, this report investigates methylation-associated metabolite (MAM) levels in MacTel patients and retinal changes in monogenetic methylation disorders. METHODS: Prospective, monocentric study on MacTel patients and healthy controls the underwent a standardized protocol including a blood draw...
January 23, 2024: Retina
https://read.qxmd.com/read/38131554/relevance-of-multicolor-imaging-its-component-channels-and-fundus-autofluorescence-in-describing-macular-telangiectasia-type-2-mactel-lesion-characteristics
#7
JOURNAL ARTICLE
Kiran Chandran, Anantharaman Giridhar, Sachin Desai, Mahesh Gopalakrishnan, V P Indu, Sobha Sivaprasad
PURPOSE: The aim of the study was to describe imaging characteristics and detection rates of phenotypic features in macular telangiectasia type-2 (MacTel) on multicolor (MC), blue reflectance (BR), green reflectance (GR), infrared reflectance (IR), and fundus autofluorescence (FAF) and to evaluate sensitivity, specificity, and predictive values across modalities. METHODS: In this monocentric observational study, 282 eyes of 148 patients with MacTel underwent color fundus photograph, MC, BR, GR, IR, FAF, spectral-domain optical coherence tomography (SD-OCT), OCT-angiography (OCT-A), and fundus fluorescein angiography (FFA)...
January 1, 2024: Indian Journal of Ophthalmology
https://read.qxmd.com/read/38108907/vitreomacular-interface-abnormalities-in-type-2-macular-telangiectasia-mactel
#8
JOURNAL ARTICLE
Ramesh Venkatesh, Rubble Mangla, Ashit Handa, Sai Prashanti Chitturi, Yash Parmar, Rohini Sangoram, Naresh Kumar Yadav, Jay Chhablani
PURPOSE: To describe the different types of vitreomacular interface abnormalities (VMIA) seen on optical coherence tomography (OCT) in type 2 macular telangiectasia (MacTel) and explain the possible reasons for its development. METHODS: In this retrospective cross-sectional study, type 2 MacTel eyes with macular volumetric OCT imaging protocol were included to identify different types of VMIA such as abnormal PVD, vitreomacular traction (VMT), ERM, and lamellar and full-thickness macular hole...
December 18, 2023: Graefe's Archive for Clinical and Experimental Ophthalmology
https://read.qxmd.com/read/38089515/clinical-features-of-macular-telangiectasia-type-2-and-comparison-of-staging-system-in-taiwanese-patients
#9
JOURNAL ARTICLE
Yan-Yu Chen, Yi-Ling Chen, Jian-Sheng Wu, San-Ni Chen
PURPOSE: The purpose of this study is to report the clinical characteristics of macular telangiectasia type 2 (MacTel 2) in Taiwan. MATERIALS AND METHODS: Retrospective analysis of patients diagnosed with MacTel 2 over a 7-year period in Changhua Christian Hospital. Best-corrected visual acuity (BCVA), fundus photography, fluorescein angiography, optical coherence tomography (OCT), and OCT angiography (OCTA) images were reviewed. Differences in BCVA and central macular thickness (CMT) were compared between the initial/baseline and final visits...
2023: Taiwan Journal of Ophthalmology
https://read.qxmd.com/read/38012385/right-angled-vessel-characteristics-in-different-stages-of-type-2-macular-telangiectasia-mactel
#10
JOURNAL ARTICLE
Ramesh Venkatesh, Ashit Handa, Sai Prashanti Chitturi, Ayushi Choudhary, Vishma Prabhu, Isha Acharya, Rubble Mangla, Naresh Kumar Yadav, Jay Chhablani
PURPOSE: To study right-angled vessels (RAV) in disease progression and macular neovascularization in type 2 macular telangiectasia (MacTel) eyes. METHODS: This retrospective image analysis study examined type 2 MacTel patients' multicolour® and OCT imaging records from January 2015 to March 2023. Age, gender, laterality, visual acuity, systemic disease, and follow-up duration were recorded. RAV characteristics were assessed using OCT and multicolour® images...
November 27, 2023: Eye
https://read.qxmd.com/read/37968753/unraveling-the-mysteries-of-macular-telangiectasia-2-the-intersection-of-philanthropy-multimodal-imaging-and-molecular-genetics-the-2022-founders-lecture-of-the-pan-american-vitreoretinal-society
#11
REVIEW
Lihteh Wu
PURPOSE: Offer a personal perspective on the scientific advances on macular telangiectasia type 2 (MacTel2) since the launch of the MacTel Project in 2005. DESIGN: Literature review and personal perspective. METHODS: Critical review of the peer-reviewed literature and personal perspective. RESULTS: Generous financial support from the Lowy Medical Research Institute laid the foundations of the MacTel Project. MacTel Project investigators used state of the art multimodal retinal imaging and advanced modern biological methods to unravel many of the mysteries surrounding MacTel2...
November 15, 2023: International Journal of Retina and Vitreous
https://read.qxmd.com/read/37919473/longitudinal-anatomical-and-visual-outcome-of-macular-telangiectasia-type-2-in-asian-patients
#12
JOURNAL ARTICLE
Kiyoto Totsuka, Shuichiro Aoki, Takahiro Arai, Kodai Kitamoto, Keiko Azuma, Ryosuke Fujino, Tatsuya Inoue, Ryo Obata
Limited information regarding the anatomical and visual prognosis of macular telangiectasia (MacTel) type 2 in the Asian population is currently available. Herein, we conducted a retrospective longitudinal analysis of Japanese patients diagnosed with MacTel type 2. Disease progression was evaluated using the Simple MacTel Classification developed by Chew EY et al. in 2023, and its association with visual changes was analyzed. Sixteen eyes of eight Japanese patients were included in the study, with an average follow-up period of 8...
November 2, 2023: Scientific Reports
https://read.qxmd.com/read/37743592/epiretinal-neovascular-membrane-in-macular-telangiectasia-type-2-multimodal-imaging-diagnosis
#13
JOURNAL ARTICLE
Carmen Antía Rodríguez-Fernández, Rahul Morwani, Luis Arias
PURPOSE: To characterize an epiretinal neovascular membrane (ERNM) through multimodal imaging in the context of a patient with Macular Telangiectasia type 2 (MacTel) and ipsilateral concomitant ocular ischemic syndrome (OIS). METHODS: Case report, with ultra-wide field (UWF) retinography, fluorescein angiography (FA), swept source optical coherence tomography (ss-OCT), and OCT-angiography (OCTA). Written informed consent for patient information and images to be published was provided by the patient...
September 24, 2023: European Journal of Ophthalmology
https://read.qxmd.com/read/37739233/developing-a-continuous-severity-scale-for-macular-telangiectasia-type-2-using-deep-learning-and-implications-for-disease-grading
#14
JOURNAL ARTICLE
Yue Wu, Catherine Egan, Abraham Olvera-Barrios, Lea Scheppke, Tunde Peto, Peter Charbel Issa, Tjebo F C Heeren, Irene Leung, Anand E Rajesh, Adnan Tufail, Cecilia S Lee, Emily Y Chew, Martin Friedlander, Aaron Y Lee
PURPOSE: Deep learning (DL) models have achieved state-of-the-art medical diagnosis classification accuracy. Current models are limited by discrete diagnosis labels, but could yield more information with diagnosis in a continuous scale. We developed a novel continuous severity scaling system for macular telangiectasia (MacTel) type 2 by combining a DL classification model with uniform manifold approximation and projection (UMAP). DESIGN: We used a DL network to learn a feature representation of MacTel severity from discrete severity labels and applied UMAP to embed this feature representation into 2 dimensions, thereby creating a continuous MacTel severity scale...
September 20, 2023: Ophthalmology
https://read.qxmd.com/read/37661066/surgical-management-of-full-thickness-macular-holes-in-macular-telangiectasia-type-2-a-global-multicenter-study
#15
JOURNAL ARTICLE
Jong G Park, Sean D Adrean, Tedi Begaj, Antonio Capone, Steve Charles, San-Ni Chen, Hung-Da Chou, Michael N Cohen, Stephanie Trejo Corona, Lisa J Faia, Sunir J Garg, Bruce R Garretson, Ninel Z Gregori, Julia A Haller, Odette Margit Houghton, Jason Hsu, Jaehyuck Jo, Richard S Kaiser, Chi-Chun Lai, Mohamed Moghazy Mahgoub, Mahsaw Mansoor, Ryo Matoba, Yuki Morizane, Marcio B Nehemy, Paul V Raphaelian, Carl D Regillo, Alan J Ruby, Margaret M Runner, Scott R Sneed, Elliott H Sohn, Marc J Spirn, James F Vander, Taku Wakabayashi, Jeremy D Wolfe, Charles C Wykoff, Yoshihiro Yonekawa, Young Hee Yoon, Tamer H Mahmoud
PURPOSE: To report on macular hole repair in macular telangiectasia type 2 (MacTel2). DESIGN: Global, multicenter, retrospective case series. PARTICIPANTS: Patients undergoing surgery for MacTel2-associated full-thickness macular hole (MTMH). METHODS: Standardized data collection sheet distributed to all surgeons. MAIN OUTCOME MEASURES: Anatomic closure and visual outcomes of MTMH. RESULTS: Sixty-three surgeries in 47 patients with MTMH were included from 30 surgeons...
September 3, 2023: Ophthalmology
https://read.qxmd.com/read/37644815/epiretinal-membrane-formation-and-optic-disc-vascularisation-in-type-2a-macular-telangiectasia-mactel
#16
JOURNAL ARTICLE
Ramesh Venkatesh, Rubble Mangla, Ashit Handa, Yash Parmar, Rohini Sangoram, Jay Chhablani
PURPOSE: To describe a rare clinical finding of epiretinal membrane (ERM) and abnormal optic disc vascularisation in type 2A macular telangiectasia (MacTel). CASE DESCRIPTION: A 52-year-old asymptomatic healthy male was examined in the retina clinic. In both eyes, corrected visual acuity was 20/20, N6. Anterior segment examination and intraocular pressure were both normal in both eyes. RESULTS: The right eye's dilated fundus examination revealed loss of retinal transparency and superficial intraretinal crystals...
August 29, 2023: European Journal of Ophthalmology
https://read.qxmd.com/read/37602186/type-3-macular-neovascularization-in-a-case-of-long-standing-macular-telangiectasia-type-2
#17
Kiran Chandran, Sachin Desai, Anantharaman Giridhar
We report a rare case of type-3 macular neovascularization (MNV) in an established case of macular telangiectasia type-2 (MacTel). A 49-year-old healthy Indian woman was diagnosed with MacTel (Gass and Blodi stage 3 in the right eye [OD] and stage 2 in the left eye [OS]) in our retina clinic in January 2004. She was subsequently seen 10 years later with MacTel progression in OD (stage 4) and drusenoid changes in both eyes. She recently complained of sudden onset diminution of vision in OS of 1 week duration...
2023: Oman Journal of Ophthalmology
https://read.qxmd.com/read/37602155/co-occurrance-of-macular-telangiectasia-type-2-with-hemorrhagic-polypoidal-choroidal-vasculopathy-and-response-to-anti-vascular-endothelial-growth-factor
#18
Shreyas Shah, George J Manayath, Shruthi Gajula, Venkatapathy Narendran
We report the case of a 57-year-old female patient who presented with defective vision in the right eye due to large hemorrhagic pigment epithelial detachment with subretinal hemorrhage near the arcades with scattered retinal pigment epithelium (RPE) alteration at the macula and minimal vitreous hemorrhage inferiorly. The left eye showed right angle perifoveal dipping venule with RPE alteration temporal to the fovea, intraretinal RPE stellate plaque at the macula area. Multimodal imaging features including color fundus photo, red-free photograph, optical coherence tomography (OCT), enhanced depth imaging OCT, fundus fluorescein angiography, indocyanine green angiography, and OCT angiography were studied along with treatment response...
2023: Oman Journal of Ophthalmology
https://read.qxmd.com/read/37559099/baseline-demographic-clinical-and-multimodal-imaging-features-of-young-patients-with-type-2-macular-telangiectasia
#19
JOURNAL ARTICLE
Nikitha Gurram Reddy, Vishma Prabhu, Sumanth Vinayak Sharma, Isha Acharya, Rubble Mangla, Naresh Kumar Yadav, Jay Chhablani, Raja Narayanan, Ramesh Venkatesh
PURPOSE: Macular telangiectasia (MacTel) type 2 is observed in patients in their 5th-8th decades of life. The clinical and imaging findings in younger patients is unknown in larger cohorts. The study purpose is to report prevalence, baseline clinical and spectral domain optical coherence tomography (SDOCT) findings in young MacTel patients below 40 years. METHODS: This hospital-based, multicentre, retrospective, cross-sectional study included patients between 2011 and 2023...
August 9, 2023: International Journal of Retina and Vitreous
https://read.qxmd.com/read/37462978/relative-ellipsoid-zone-reflectivity-in-macular-telangiectasia-type-2
#20
JOURNAL ARTICLE
Lukas Goerdt, Leonie Weinhold, Ben Isselmann, Jose Luis Rodriguez Garcia, Sandrine H Künzel, Matthias Schmid, Frank G Holz, Simone Tzaridis, Sarah Thiele
PURPOSE: The relative ellipsoid zone reflectivity (rEZR) has been proposed as an innovative biomarker for photoreceptor integrity. This study evaluates the rEZR in macular telangiectasia type 2 (MacTel) eyes of different disease stages. METHODS: The mean rEZR (ratio ellipsoid zone [EZ]/external limiting membrane [ELM] reflectivity [arbitrary units {AUs}], grey level range = 0-1) was analyzed for an entire spectral domain optical coherence tomography volume scan (global) and for each subfield of the Early Treatment Diabetic Retinopathy Study (ETDRS) grid (topographic) in patients with MacTel and controls...
July 3, 2023: Investigative Ophthalmology & Visual Science
keyword
keyword
47678
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.